Tumour Treating Fields for mesothelioma-Reference-Cited by-同舟云学术

Tumour Treating Fields for mesothelioma

Published:2020-01 Issue:1 Volume:21 Page:e8
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Barbarino Marcella,Bottaro Maria,Luzzi Luca,Giordano Antonio,Mutti Luciano

Publisher

Elsevier BV

Subject

Oncology

Reference6 articles.

1. Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm, prospective, phase 2 trial;Ceresoli;Lancet Oncol,2019

2. P3.03-036 Prognostic Model for Mesothelioma Based on Cancer and Leukemia Group B (CALGB) Trials (Alliance);Pang;J Thorac Oncol,2017

3. Survival in good performance malignant pleural mesothelioma patients; prognostic factors and predictors of response;Rahouma;Asian Pac J Cancer Prev,2017

4. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

5. Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation;Kim;Oncotarget,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology;Journal of Translational Medicine;2022-12-13

2. Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma;BMC Pulmonary Medicine;2021-05-05

3. Is There Already a Need of Reckoning on Cancer Immunotherapy?;Frontiers in Pharmacology;2021-03-26